John E. Davis - 23 Feb 2024 Form 4/A Insider Report for ARTIVION, INC. (AORT)

Role: Chief Commercial Officer
Signature: /s/ John E. Davis
Issuer symbol: AORT
Transactions as of: 23 Feb 2024
Net transactions value: -$70,158
Form type: 4/A
Filing time: 14 Mar 2024, 20:27:15 UTC
Date Of Original Report: 28 Feb 2024
Previous filing: 22 Feb 2024
Next filing: 29 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AORT	Common Stock	Award	$0	+5,386	+3.6%	$0.000000	153,279	23 Feb 2024	Direct	F1
transaction	AORT	Common Stock	Sale	$32,150	-1,586	-1%	$20.27	151,711	26 Feb 2024	Direct	F2, F3
transaction	AORT	Common Stock	Award	$0	+12,736	+8.4%	$0.000000	164,447	23 Feb 2024	Direct	F3, F4
transaction	AORT	Common Stock	Sale	$38,008	-1,875	-1.1%	$20.27	162,572	26 Feb 2024	Direct	F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.
F2	These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,610 shares were sold, when in fact, 1,586 shares were sold.
F3	As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.
F4	Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.
F5	These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,904 shares were sold, when in fact, 1,875 shares were sold.